1-13 of 13
Gorgun Akpek, MD, MHS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Laura A. Zider, MSN, ACNP-BC, RN, Amanda N. Seddon, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Jamile M. Shammo, MD, Gorgun Akpek, MD MHS
Journal: Blood
Blood (2016) 128 (22): 5876.
https://doi.org/10.1182/blood.V128.22.5876.5876
Published: 2016
Journal Articles

Evaluation of Immune Recovery Following Autologous Hematopoietic Cell Transplantation in HIV-Related Lymphoma: Results of the BMT CTN 0803/AMC 071 Trial

Mat Makowski, PhD, Elshafa Ahmed, DVM, Sarah Schlotter, B.S., Rebecca Pearson, Rhonda Kitzler, MS, Joseph C. Alvarnas, MD, Jennifer Le Rademacher, PhD, Yanli Wang, PhD, Richard F Little, MDMPH, Gorgun Akpek, MD MHS, FACP, Ernesto Ayala, MD, Steven M. Devine, Lawrence D. Kaplan, MD, Ariela Noy, MD PhD, Uday R. Popat, MD, Jack W Hsu, MD, Lawrence E. Morris, MD, Jason Thompson, Mary H Horowitz, MD MS, Adam M. Mendizabal, PhD, Alexandra M. Levine, MD, Amrita Krishnan, MD, Erinn Hade, Craig C Hofmeister, Stephen J. Forman, MD, Willis H. Navarro, MD, Richard F. Ambinder, MD PhD, Gerard Lozanski, MD, Robert A Baiocchi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1346.
https://doi.org/10.1182/blood.V128.22.1346.1346
Published: 2016
Journal Articles

Bridging to Second Allogeneic Peripheral Blood Stem Cell Transplantation with Nelarabine in a Patient with Multiply Relapsed/Refractory T-Cell ALL

Jacqueline Baptista, RN, APN, Eris Tollkuci, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Melissa L. Larson, MD, Gorgun Akpek, MD MHS
Journal: Blood
Blood (2016) 128 (22): 5200.
https://doi.org/10.1182/blood.V128.22.5200.5200
Published: 2016
Journal Articles

Successful Early Outcome with Low-Dose (400 cGY) Total Body Irradiation in Combination with Busulfan and Fludarabine Myeloablative Conditioning Followed By Matched Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Non-Remission Acute Myelogeneous Leukemia with Diffuse Extramedullary Disease in Multiple Sites

Gorgun Akpek, MD MHS, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Deborah A. Katz, MD, Ashley Echeverria, PA-C, Lindsay Hodges, RN, APN, Aidnag Z. Diaz, MD MPH, Ross Allen Abrams, MD
Journal: Blood
Blood (2016) 128 (22): 5769.
https://doi.org/10.1182/blood.V128.22.5769.5769
Published: 2016
Journal Articles

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Andrew S. Artz, MD MS, Brent R. Logan, PhD, Xiaochun Zhu, MS, Görgün Akpek, MD MHS, Rodrigo Martino, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Alison Wakoff Loren, MD MS, Navneet S. Majhail, MD MS, Richard T. Maziarz, MD, Philip L. McCarthy, MD, Uday R. Popat, MD, Wael Saber, MD MS, Stephen R. Spellman, MBS, Olle Ringdén, MDPhD, Kenneth R. Cooke, MD, Marcelo C. Pasquini, MD MS
Journal: Blood
Blood (2014) 124 (21): 422.
https://doi.org/10.1182/blood.V124.21.422.422
Published: 2014
Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Nandita Khera, MD MPH, Navneet S. Majhail, MD MS, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Mahmoud Aljurf, MD, Görgün Akpek, MD MHS, Yoshiko Atsuta, MDPhD, Sara Beattie, BSc(Hons), Christopher N. Bredeson, MD MSc, FRCPC, Linda J. Burns, MD, Allen R. Chen, MD PhD MHS, Jason Dehn, MPH, CHTC, César O Freytes, MD, Vikas Gupta, MD FRCP, FRCPath, Gregory A. Hale, MD, Yoshihiro Inamoto, MD PhD, Hillard M. Lazarus, MD, Charles F. LeMaistre, MD, Jeanne M. Palmer, MD, Kristjan Paulson, MD FRCPC, Raquel M. Schears, MD MPH, FACEP, Amir Steinberg, MD, David Szwajcer, MD FRCPC, John R. Wingard, MD, Baldeep Wirk, MD, William A. Wood, MD MPH, Steven Joffe, MD MPH, Theresa Hahn, PhD, Fausto R. Loberiza, MD MS, Stephanie J. Lee, MD MPH
Journal: Blood
Blood (2014) 124 (21): 209.
https://doi.org/10.1182/blood.V124.21.209.209
Published: 2014
Journal Articles

Final Report of Safety and Efficacy From a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation.

Edward A. Stadtmauer, MD, Voravit Ratanatharathorn, MD, Rosa F. Yeh, PharmD, Cesar O. Freytes, MD, Juan J. Toro, MD, MSci, Gorgun Akpek, MD, MHS, Entezam A. Sahovic, MD, Guido J. Tricot, MD, PhD, Paul J. Shaughnessy, MD, Darrell J. White, MD, Tulio E. Rodriguez, MD, Scott R. Solomon, MD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Donna Reece
Journal: Blood
Blood (2012) 120 (21): 3080.
https://doi.org/10.1182/blood.V120.21.3080.3080
Published: 2012
Journal Articles

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Aaron P. Rapoport, MD, Nicole A. Aqui, MD, Edward A. Stadtmauer, MD, Ashraf Z. Badros, MD, Dan T. Vogl, MD, MSCE, YinYan Xu, Brendan M Weiss, MD, Ling Cai, PhD, Hong-Bin Fang, PhD, Elizabeth Veloso, RN, JD, Zhaohui Zheng, MA, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Sunita Philip, Kathleen Ruehle, RN, Kelly-Marie Betts, MS, Anne Chew, PhD, Holly McConville, RN, BSN, Sandra Westphal, Scott Strome, Andres Salazar, MD, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 352.
https://doi.org/10.1182/blood.V120.21.352.352
Published: 2012
Journal Articles

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nick J. Pumphrey, PhD, Dominic P. Smethurst, MD, Helen K. Tayton-Martin, PhD, Ribeiro C. Lilliam, MBe, Elizabeth Veloso, JD, BSN, Zhaohui Zheng, MA, Ashraf Z. Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Holly McConville, RN, BSN, Naseem Kerr, MPH, Sunita Philip, MPH, Kelly-Marie Betts, MS, Sandra Westphal, Michael Kalos, PhD, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 472.
https://doi.org/10.1182/blood.V120.21.472.472
Published: 2012
Journal Articles

Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1

Michael Kalos, PhD, Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Dominic P. Smethurst, MD, Irina Kulikovskaya, Minnal Gupta, Timothy L Macatee, Jeffrey M Finklestein, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nick J. Pumphrey, PhD, Helen K. Tayton-Martin, PhD, Elizabeth Veloso, JD, BSN, Zhaohui Zheng, MA, Ashraf Z. Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Holly McConville, RN, BSN, Sunita Philip, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 755.
https://doi.org/10.1182/blood.V120.21.755.755
Published: 2012
Journal Articles

Pharmacokinetics and Safety of a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

Cesar O. Freytes, MD, Juan J. Toro, MD, MSci, Rosa F. Yeh, PharmD, Edward A. Stadtmauer, MD, Voravit Ratanatharathorn, MD, Gorgun Akpek, MD, MHS, Entezam Sahovic, MD, Guido J. Tricot, MD, PhD, Paul J. Shaughnessy, MD, Darrell J. White, MD, Tulio E. Rodriguez, MD, Scott R. Solomon, MD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Donna E. Reece, MD, FRCPC
Journal: Blood
Blood (2011) 118 (21): 4509.
https://doi.org/10.1182/blood.V118.21.4509.4509
Published: 2011
Journal Articles

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Minoo Battiwalla, MD, MS, Kristin Ellis, PhD, Steven Z. Pavletic, MD, Gorgun Akpek, MD, MHS, Peiman Hematti, MD, Thomas R Klumpp, MD, Richard T. Maziarz, MD, Bipin N. Savani, MD, Mahmoud Aljurf, MD, Mitchell S. Cairo, MD, William R. Drobyski, MD, Biju George, MD, Theresa Hahn, PhD, Nandita Khera, Mark R. Litzow, MD, Alison W. Loren, MD, Wael Saber, MD, MS, Mukta Arora, MD, Alvaro Urbano-Ispizua, MD, Corey S. Cutler, MD, MPH, FRCPC, Mary E.D. Flowers, MD, Stephen Spellman, MBS
Journal: Blood
Blood (2011) 118 (21): 3094.
https://doi.org/10.1182/blood.V118.21.3094.3094
Published: 2011
Journal Articles

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Gorgun Akpek, MD, MHS, Ashraf Badros, MD, Aaron P. Rapoport, MD, Kathleen Ruehle, RN, Kristen Barton, RN, Barry Meisenberg, MD, Saul Yanovich, MD
Journal: Blood
Blood (2006) 108 (11): 5254.
https://doi.org/10.1182/blood.V108.11.5254.5254
Published: 2006